Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on October 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

DANTROLENE SODIUM F

Closed
SPE2DP-26-T-5359Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5359 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Dantrolene Sodium Injection, USP. The requirement is for three vials of 250mg injection (20ml per vial) under NSN 6505-01-653-1569. The product is FDA regulated and must be stored at controlled room temperature between 20 to 25 degrees Celsius while avoiding exposure to light. The item is classified as a Type I Code M item with a non-extendable shelf life of 24 months. Delivery is required by March 23, 2026, with a delivery timeline of five days after order. Shipping is FOB Destination to the Medical Logistics facility at Fort Bragg, North Carolina, and must be sent via the fastest traceable means. Packaging must be commercial and sealed to prevent damage, adhering to ASTM D3951 unless the material is hazardous, in which case TQ requirement IP025 applies. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Invoicing and payment shall be processed electronically through the Wide Area WorkFlow system.

General Info

DLA seeks three 250mg Dantrolene Sodium Injection vials delivered to Fort Bragg by 2026.

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this first18 pages · rfq
High

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Beauty Product & Accessory SupplyOpen now, due in 4 days
  • Supply of Regular Absorbency Sanitary TamponsOpen now, due in 7 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
DANTROLENE SODIUM F
DANTROLENE SODIUM INJECTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
250MG INJECTION
.
UNIT OF ISSUE "VIAL"
.
1 VI = 20 ML
LABELS SHALL INCLUDE:
NSN
MANUFACTURER AND CAGE
SPE2DP-26-T-5359
SECTION B
DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE CONTRACT NUMBER/LOT
NUMBER.
.
STORE UNRECONSTITUTED PRODUCT AT 20 TO 25 DEGREES CELSIUS (68-77 DEGREES
FAHRENHEIT) USP CONTROLLED ROOM TEMPERATURE; AVOID EXPOSURE TO LIGHT.
.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
CARDINAL HEALTH, INC. 00E55 P/N NDC42367-0540-32 AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC42367-0540-32 EAGLE PHARMACEUTICALS, INC. 7LL94 P/N NDC42367-0540-32
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015989572 0001 VI 3.000
NSN/MATERIAL:6505016531569
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951.
SPE2DP-26-T-5359
SECTION B
PR: 7015989572 PRLI: 0001 CONT’D
Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF260760010
RDD: 091
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:03/23/2026
SPE2DP-26-T-5359 NSN/Part Number: 6505-01-653-1569 Quantity: 3 VI Purchase Request: 7015989572QTY: 3 Delivery: 5 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
OMEPRAZOLE EXTENDED-RE
Solicitation # SPE2DP-27-T-0387
Solicitation SPE2DP-27-T-0387 is a small business set-aside procurement for the supply of 8 bottles of Omeprazole Extended-Release Capsules. The product consists of 20 mg delayed release capsules provided in 90-count bottles, which are regulated by the FDA and must be stored at controlled room temperature. The items have a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon delivery to the first government activity. Delivery is required within 20 days, with an original required delivery date of November 17, 2026, shipped FOB Destination to the US Army 299 BSB 2ABCT FOS DCTC in Drawsko Pomorskie, Poland. Packaging and marking must adhere to strict standards, specifically Medical Marking Standard No. 1 and MED. MKT STD 1A, which supersede MIL-STD-129. Each unit must be in a sealed container to prevent damage, and shipping must follow ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. Inspection and acceptance will occur at the destination. The contract incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information, combating trafficking in persons, and compliance with the Buy American Act. All quotes and invoicing must be processed through the DLA Internet Bid Board System and the Wide Area WorkFlow system, respectively.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 5 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
CHARCOAL, ACTIVATED, SUS
Solicitation # SPE2DP-27-T-0383
Solicitation SPE2DP-27-T-0383 is a small business set-aside procurement for the Department of Defense, specifically the Medical Supply Chain Pharm FSA, for the supply of activated charcoal suspension. The requirement is for four bottles, each containing 50 grams in a 240 ml volume (NSN 6505-01-282-880), with a required delivery date of November 17, 2026. Delivery is specified as FOB Destination to a shipping address in Poland, with a required delivery timeline of 20 days after order. The material must be stored between 20 and 25 degrees Celsius and must have a shelf life of 36 months, with no more than five months elapsed from the date of manufacture to the date of delivery. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Marking must follow Medical Marking Standard No. 1, and labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and receiving reports. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, cybersecurity safeguarding, and hazardous material identification. Inspection and acceptance will be performed at the destination per FAR 52.246-2.
Pharmaceutical Preparation Manufacturing

POSTED

about 5 hours ago

DEADLINE

in 7 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS